3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34824002 | A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC). | 2022 Apr | 1 |
| 2 | 27826831 | Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer. | 2017 Feb | 1 |
| 3 | 25537627 | A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer. | 2015 Feb | 2 |